Review Article
Steps and challenges in the implementation of a plasma fractionation program: Brazil experience
Annals of Blood
2018;
3:
26
(17 April 2018)
Perspective
Role of the quality assurance person in the production of recovered plasma for fractionation
Annals of Blood
2018;
3:
25
(17 April 2018)
Letter to the Editor
The development of plasma-derived factor VIII concentrates
Annals of Blood
2018;
3:
24
(30 March 2018)
Viewpoint
Blood tubes should be appropriately labelled and checked by the patient before departure
Annals of Blood
2018;
3:
23
(21 March 2018)
Mini-Review
Role of the mini-pool cryoprecipitate technology for cost-saving and guarantee of local Factor VIII, Von Willebrand Factor and Fibrinogen product supply: Egypt experience
Annals of Blood
2018;
3:
22
(13 March 2018)
Original Article
Role of virus inactivated cryoprecipitate in the treatment of bleeding disorders
Annals of Blood
2018;
3:
21
(07 March 2018)
Perspective
Factor VIII manufactured from plasma—the ups and downs, and the up again: a personal journey—part 2: aspects of factor VIII manufacture from plasma
Annals of Blood
2018;
3:
20
(28 February 2018)
Perspective
Recent market status and trends of fractionated plasma products
Annals of Blood
2018;
3:
19
(28 February 2018)
Editorial
Cardiovascular genetics: a super-bright or over-hyped perspective?
Annals of Blood
2018;
3:
18
(28 February 2018)
Perspective
Factor VIII manufactured from plasma—the ups and downs, and the up again: a personal journey—part 1: history of the development of plasma-derived factor VIII therapies
Annals of Blood
2018;
3:
17
(28 February 2018)
Viewpoint
Labeling tubes before collection threatens patient safety
Annals of Blood
2018;
3:
16
(26 February 2018)
Perspective
Plasma fractionation in China: progress and challenges
Annals of Blood
2018;
3:
15
(26 February 2018)
Review Article
Building blocks of the viral safety margins of industrial plasma products
Annals of Blood
2018;
3:
14
(26 February 2018)
Meet the Professor
Profs. Erica Wood and Masahiro Satake—sharing, learning and improving
Annals of Blood
2018;
3:
13
(05 February 2018)
Meet the Professor
Prof. Steve Henry: Kode technology—a magic biological paint
Annals of Blood
2018;
3:
12
(02 February 2018)
Meet the Professor
Interview with Prof. Roger Y. Dodd and Prof. Susan L. Stramer: pathogen inactivation, a technology that will help reduce the emerging infections
Annals of Blood
2018;
3:
11
(02 February 2018)
Meet the Professor
Interview with Prof. Martin L. Olsson—meeting the challenge of blood group genotyping to provide safe blood for transfusion
Annals of Blood
2018;
3:
10
(02 February 2018)
Original Article
Diagnosis and management of von Willebrand disease in Slovakia
Annals of Blood
2018;
3:
9
(01 February 2018)
Meet the Professor
Interview with Prof. Evan Martin Bloch—public and clinical awareness of babesiosis is critical
Annals of Blood
2018;
3:
8
(01 February 2018)
Review Article
Von Willebrand disease in the United States: perspective from the Zimmerman program
Annals of Blood
2018;
3:
7
(26 January 2018)
Review Article
Plasma fractionation in South Africa: challenges and successes in meeting international standards
Annals of Blood
2018;
3:
6
(23 January 2018)
Review Article
Diagnosis and management of von willebrand disease in Spain
Annals of Blood
2018;
3:
5
(22 January 2018)
Review Article
Von Willebrand disease in Iran: diagnosis and management
Annals of Blood
2018;
3:
4
(21 January 2018)
Review Article
Regulation of plasma for fractionation in the United States
Annals of Blood
2018;
3:
3
(17 January 2018)
Review Article
Von Willebrand disease—the Nordic perspective
Annals of Blood
2018;
3:
2
(15 January 2018)